While various clinical applications especially in oncology are now in progress such as
diagnosis, prognosis, therapy monitoring, or patient follow-up, the determination of structural …

The outbreak of COVID-19 has positively impacted the NGS market recently. Targeted
sequencing (TS) has become an important routine technique in both clinical and research …

Background: Laboratory monitoring of mother, fetus, and newborn in hemolytic disease of
fetus and newborn (HDFN) aims to guide clinicians and the immunized women to focus on …

Anti-D immunoglobulin prophylaxis reduces the risk of RhD negative women becoming
alloimmunised to the RhD antigen and is a major preventative strategy in reducing the …

Hemolytic disease of fetus and newborn (HDFN) imposes great healthcare burden being
associated with maternal alloimmunization against parental-inherited fetal red blood cell …

Non‐invasive prenatal tests (NIPT) to predict fetal red cell or platelet antigen status for
alloimmunised women are provided for select antigens. This study reports on massively …

Non-invasive fetal HPA-1a typing is a valuable tool to identify the pregnancies at risk of fetal
and neonatal alloimmune thrombocytopenia (FNAIT). At present, prenatal determination of …

Introduction: In the fight against hemolytic disease of the fetus and newborn, pregnant RhD
negative women are offered antenatal and postnatal anti-D immunoglobulin prophylaxis to …

Predicting blood group phenotypes from DNA sequence, an alternative method to
conventional blood group serology, began shortly after the molecular genetic bases of many …

Advances in prenatal/neonatal genetic screening practices and next generation sequencing
(NGS) technologies have made the detection of molecular causes of pediatric diseases …